The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Immunome Inc shares valued at $230,224 were sold by Rosett Max on Sep 19 ’24. At $16.01 per share, Rosett Max sold 14,380 shares. The insider’s holdings dropped to 47,476 shares worth approximately $0.68 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Rosett Max purchased 14,380 shares, netting a total of over 230,211 in proceeds.
Before that, BIENAIME JEAN JACQUES had added 7,000 shares to its account. In a trade valued at $97,608, the Director bought Immunome Inc shares for $13.94 each. Upon closing the transaction, the insider’s holdings increased to 7,000 shares, worth approximately $0.24 million.
As published in their initiating research note from Piper Sandler on May 31, 2024, Immunome Inc [IMNM] has been an Overweight and the price target has been revised to $27. Analysts at JP Morgan started covering the stock with ‘”an Overweight”‘ outlook in a report released in late April. As of April 15, 2024, Guggenheim has initiated its “Buy” rating for IMNM. Earlier on January 29, 2024, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for IMNM stock.
Analyzing IMNM Stock Performance
During the last five days, there has been a drop of approximately -6.21%. Over the course of the year, Immunome Inc shares have jumped approximately 34.02%. Shares of the company reached a 52-week high of $30.96 on 03/07/24 and a 52-week low of $10.38 on 01/02/24. A 50-day SMA is recorded $14.53, while a 200-day SMA reached $16.12. Nevertheless, trading volume fell to 0.61 million shares from 0.52 million shares the previous day.
Support And Resistance Levels for Immunome Inc (IMNM)
According to the 24-hour chart, there is a support level at 13.92, which, if violated, would cause prices to drop to 13.49. In the upper region, resistance lies at 14.76. The next price resistance is at 15.17. RSI (Relative Strength Index) is 47.20 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.49, which suggests the price will decrease in the coming days. Percent R is at 76.97%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
